ConductScience.org, home

Paper5000612

Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.

Marks MI and 4 others. J Pediatr, 1971. Cited by 78 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. Papers, record 5000612. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5000612

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.
PubMed
Journal
J Pediatr
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
4.29
iCite
Revised in PubMed
2019-06-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marks MIM I
2Prentice RR
3Swarson RR
4Cotton EKE K
5Eickhoff TCT C

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Drug SynergismMajor topic
GentamicinsMajor topic
Lung DiseasesMajor topic
PenicillinsMajor topic
Pseudomonas InfectionsMajor topic
Adolescent
Carbenicillin
Child
Child, Preschool
Female
Humans
Injections, Intravenous
Male
Pseudomonas aeruginosa
Sputum
Time Factors

Source PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
7,436,516Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.Arch Dis Child1980https://conductscience.org/library/papers/7436516PubMed
7,247,362Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247362PubMed
7,094,939Sputum penetration of fusidic acid in patients with cystic fibrosis.Eur J Pediatr1982https://conductscience.org/library/papers/7094939PubMed
6,810,757Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6810757PubMed
6,790,439Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate.Infect Immun1981https://conductscience.org/library/papers/6790439PubMed
6,776,135Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.J Clin Microbiol1980https://conductscience.org/library/papers/6776135PubMed
6,460,337Penetration of piperacillin into bronchial mucosa and sputum.Thorax1981https://conductscience.org/library/papers/6460337PubMed
6,413,411Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.Infect Immun1983https://conductscience.org/library/papers/6413411PubMed
4,198,594Pediatric antimicrobial therapy. II.Can Med Assoc J1973https://conductscience.org/library/papers/4198594PubMed
3,312,023Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review).Infection1987https://conductscience.org/library/papers/3312023PubMed
3,118,798In vitro activity of aztreonam combined with tobramycin and gentamicin against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3118798PubMed
3,080,408Gene amplification induces mucoid phenotype in rec-2 Pseudomonas aeruginosa exposed to kanamycin.J Bacteriol1986https://conductscience.org/library/papers/3080408PubMed
1,724,642Drug treatment of pneumonia in the hospital. What are the choices?Drugs1991https://conductscience.org/library/papers/1724642PubMed
596,926Gentamicin dosage in preterm and term neonates.Arch Dis Child1977https://conductscience.org/library/papers/596926PubMed
533,258Bronchial secretion levels of amikacin.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/533258PubMed
383,354Clinical pharmacokinetics of aminoglycoside antibiotics.Clin Pharmacokinet1979https://conductscience.org/library/papers/383354PubMed
96,088Biosynthesis of exopolysaccharide by Pseudomonas aeruginosa.J Bacteriol1978https://conductscience.org/library/papers/96088PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5000612

GET https://conductscience.org/api/papers/v1/5000612/authors